Integral Health Asset Management, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Integral Health Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	BUY	$7.6 - $11.41 $485,108 - $728,300	63,830 Added 37.33%	234,830 $2.28 Million
Q1 2022 May 12, 2022	BUY	$9.3 - $12.37 $288,300 - $383,470	31,000 Added 22.14%	171,000 $1.7 Million
Q4 2021 Feb 02, 2022	BUY	$10.39 - $15.15 $1.45 Million - $2.12 Million	140,000 New	140,000 $1.65 Million
Q1 2021 May 10, 2021	SELL	$16.68 - $23.97 $2.25 Million - $3.24 Million	-135,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.8 - $21.15 $222,000 - $317,250	15,000 Added 12.5%	135,000 $2.39 Million
Q3 2020 Nov 16, 2020	BUY	$15.21 - $25.53 $1.83 Million - $3.06 Million	120,000 New	120,000 $1.84 Million

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.